Related Experiment Video
Updated: Jun 1, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
SPARC stimulates neuronal differentiation of medulloblastoma cells via the Notch1/STAT3 pathway
Praveen Bhoopathi1, Chandramu Chetty, Ranadheer Dontula
1Program of Cancer Biology, Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
Abstract:
Secreted protein acidic and rich in cysteine (SPARC) participates in the regulation of morphogenesis and cellular differentiation through its modulation of cell-matrix interactions. We previously reported that SPARC expression significantly impairs medulloblastoma tumor growth in vivo. In this study, we show that adenoviral-mediated overexpression of SPARC cDNA (Ad-DsRed-SP) elevated the expression of the neuronal markers NeuN, nestin, neurofilament, and MAP-2 in medulloblastoma cells and induced neuron-like differentiation. SPARC overexpression decreased STAT3 phosphorylation; constitutive expression of STAT3 reversed SPARC-mediated expression of neuronal markers. We also show that Notch signaling is suppressed in the presence of SPARC, as well as the Notch effector basic helix-loop-helix (bHLH) transcription factor hairy and enhancer of split 1 (HES1). Notch signaling was found to be responsible for the decreased STAT3 phosphorylation in response to SPARC expression. Furthermore, expression of SPARC decreased the production of interleukin 6 (IL-6) and supplemented IL-6-abrogated, SPARC-mediated suppression of Notch signaling and expression of neuronal markers. Immunohistochemical analysis of tumor sections from mice treated with Ad-DsRed-SP showed increased immunoreactivity for the neuronal markers and a decrease in Notch1 expression and phosphorylation of STAT3. Taken together, our results suggest that SPARC induces expression of neuronal markers in medulloblastoma cells through its inhibitory effect on IL-6-regulated suppression of Notch pathway-mediated STAT3 signaling, thus giving further support to the potential use of SPARC as a therapeutic candidate for medulloblastoma treatment. Findings show that SPARC-induced neuronal differentiation can sensitize medulloblastoma cells for therapy.
Insights
Secreted protein acidic and rich in cysteine (SPARC) promotes neuronal differentiation in medulloblastoma cells. SPARC inhibits IL-6 signaling, activating Notch and decreasing STAT3 phosphorylation, suggesting therapeutic potential for medulloblastoma.
Area of Science:
- Oncology
- Neuroscience
- Molecular Biology
Background:
- Secreted protein acidic and rich in cysteine (SPARC) regulates cell-matrix interactions and differentiation.
- Previous studies indicated SPARC impairs medulloblastoma tumor growth in vivo.
- Medulloblastoma is a common pediatric brain tumor requiring novel therapeutic strategies.
Purpose of the Study:
- To investigate the mechanisms by which SPARC influences medulloblastoma cell differentiation.
- To explore the role of SPARC in modulating signaling pathways involved in medulloblastoma progression.
- To evaluate SPARC as a potential therapeutic agent for medulloblastoma.
Main Methods:
- Adenoviral-mediated overexpression of SPARC cDNA in medulloblastoma cells.
- Analysis of neuronal marker expression (NeuN, nestin, neurofilament, MAP-2).
- Assessment of STAT3 phosphorylation, Notch signaling, HES1, and IL-6 production.
Main Results:
- SPARC overexpression induced neuron-like differentiation and increased neuronal marker expression.
- SPARC decreased STAT3 phosphorylation and suppressed Notch signaling and HES1 expression.
- SPARC reduced IL-6 production; IL-6 blockade reversed SPARC-mediated effects.
- Tumor analysis showed increased neuronal markers and decreased Notch1/pSTAT3 in SPARC-treated mice.
Conclusions:
- SPARC induces neuronal differentiation in medulloblastoma by inhibiting IL-6-mediated suppression of Notch/STAT3 signaling.
- SPARC demonstrates potential as a therapeutic candidate for medulloblastoma.
- SPARC-induced differentiation may sensitize medulloblastoma cells to therapy.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
The JAK-STAT Signaling Pathway

